IRIS Centre, School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin, Ireland
National Quality and Patient Safety Directorate, Health Service Executive, Dublin, Ireland.
BMJ Open. 2023 Jul 14;13(7):e071382. doi: 10.1136/bmjopen-2022-071382.
Composite indicators of quality and safety in healthcare summarise performance across multiple indicators into a single performance measure. Composite indicators can identify domains and drivers of quality, improve the ability to detect differences, aid prioritisation for quality improvement and facilitate decision making about future healthcare needs. However, the use of composite indicators can be controversial, particularly when used to rank healthcare providers. Many of the concerns around transparency, appropriateness and uncertainty may be addressed by a robust and transparent development and review process.The aim of this scoping review is to describe methodologies used at each of the stages of development of composite indicators of quality and safety in healthcare. This review will provide those tasked with developing or reviewing composite indicators with a valuable consolidated analysis of a substantial and wide-ranging literature.
The framework proposed by the Joanna Briggs Institute and enhancements proposed by Peters (2015, 2017, 2020) will be used in conducting this scoping review, and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for scoping reviews will guide the reporting. Grey literature and peer-reviewed documents will be in-scope. Electronic databases (PubMed, Embase, CINAHL, ABI/INFORM and SafetyLit) will be searched, and publications will be screened by two reviewers. Discussion, policy and guidance publications will be included if they discuss any aspect of the methods used in the development of a composite indicator of quality or safety in a healthcare setting. The search period ranges from 1 January 2000 to 31 December 2022. Data extraction will capture information on 11 stages of composite indicator development, augmenting a 10-stage framework developed by the European Commission Joint Research Centre.
Ethical approval is not required. Review findings will be published in a peer-reviewed journal and presented at scientific conferences.
医疗保健质量和安全的综合指标将多个指标的绩效综合为一个单一的绩效衡量标准。综合指标可以确定质量的领域和驱动因素,提高检测差异的能力,有助于确定质量改进的优先级,并为未来的医疗保健需求做出决策。然而,使用综合指标可能存在争议,特别是在用于对医疗保健提供者进行排名时。许多关于透明度、适当性和不确定性的担忧,可以通过一个强大和透明的开发和审查过程来解决。本研究旨在描述医疗保健质量和安全综合指标开发过程各个阶段使用的方法。本综述将为负责开发或审查综合指标的人员提供有价值的综合分析,涵盖广泛而广泛的文献。
将使用 Joanna Briggs 研究所提出的框架以及 Peters (2015 年、2017 年、2020 年)提出的增强功能来进行这项范围界定综述,并将循证卫生保健研究所系统评价和荟萃分析扩展范围综述的报告标准指导报告。灰色文献和同行评议文献将在范围内。将搜索电子数据库(PubMed、Embase、CINAHL、ABI/INFORM 和 SafetyLit),并由两名评审员筛选出版物。如果讨论了医疗保健环境中质量或安全综合指标开发中使用的任何方法方面的讨论、政策和指导出版物将包括在内。搜索期从 2000 年 1 月 1 日至 2022 年 12 月 31 日。数据提取将捕获综合指标开发的 11 个阶段的信息,补充欧盟联合研究中心开发的 10 个阶段框架。
不需要伦理批准。审查结果将发表在同行评议的期刊上,并在科学会议上展示。